PRESS RELEASE
FACTSHEET
Clinical trials are becoming increasingly decentralized, and Q2 Solutions is committed to discovering new and innovative ways to improve the participant and investigator experience.
Today, clinical study participants in the United States can collect a blood specimen for a safety lab test in the comfort of their own home using the Tasso+ device, eliminating the need to travel to an investigator site or have a healthcare professional visit their home.
The initial self-collection service is specifically a liver function panel designed to help diagnose and monitor liver disease or damage by measuring the levels of select enzymes, proteins, and compounds in the blood. The panel includes tests for ALT (alanine transaminase), AST (aspartate aminotransferase), ALP (alkaline phosphatase), total bilirubin, direct bilirubin, total protein, and albumin.
Liver Panel Specifications | ||
Analytes | Total Protein, Albumin, ALP, ALT, AST, Direct Bilirubin, & Total Bilirubin | |
Volume Collected | 300 – 500 µL | |
Regions Available | United States to start | |
Turnaround Time | Treated as safety tests, samples will be tested same day of receipt |
Q2 Solutions’ leading clinical laboratory testing solutions combined with Tasso’s clinical-grade sampling technology, deliver remote laboratory testing without sacrificing specimen quality.
The process is simple:
We are contributing to the success of decentralized clinical trials by reaching study participants where they live to perform remote safety laboratory tests. Our self-collection safety liver panel was designed with the study participant and trial investigator in mind. We aim to improve participant convenience and deliver a better experience, as well as support investigators by reducing their workload.
Enhancing the experience of participants by reducing their burden has secondary advantages as well. Because it is more convenient for participants to collect their own specimens, self-collection has the potential to increase trial enrollment by broadening access to a larger number of participants and perhaps even a more diverse pool.
A liquid blood collection device that allows for volumes 300-600 µL
The participant places the device on his/her shoulder (after cleansing the area with an alcohol pad) and presses the red button to start the blood collection. A lancet is released and pricks the skin, a vacuum is created, and capillary blood is collected into the attached SST tube. See video for more details.